Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

IAVI Report

Persistence pays: Researchers unravel mechanism of protection for a potential HIV vaccine vector

May 25, 2022

Scientists explain why a cytomegalovirus-vectored vaccine candidate, nearly 20 years in the making, produces promising results in monkeys. Will the same be true in humans?

Read more

Press Releases

IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program

May 18, 2022

Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity.

Read more

Scientific Publications

HIV vaccines in 2022: where to from here?

Read more

Features

HVAD 2022: An HIV vaccine developed with the people it seeks to benefit most

May 17, 2022

On this HVAD, our colleagues share perspectives on how an HIV vaccine can be developed with the people it seeks to benefit most.

Read more

In The News

After 40 years, researchers discover new frontiers in the fight against HIV

Pharma Voice

May 16, 2022

Read more

Scientific Publications

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

Read more

Scientific Publications

Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda

Read more

Scientific Publications

Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study

Read more